Pharmaceutical Investing Clementia Initiates Phase 2 MO-Ped Trial for Palovarotene in Patients with Multiple Osteochondromas
Pharmaceutical Investing Reata Announces Kyowa Hakko Kirin Received SAKIGAKE Priority Review Designation for Bardoxolone Methyl in Japan
AnaptysBio Announces Positive Top-Line Proof-of-Concept Data For ANB020 In Moderate-to-Severe Baseline
Pharmaceutical Investing Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab Presented at IDWeek 2017™
175m @ 2.5% Copper from 7.6m, Hole Ends in 4.46% Copper & Open at Depth Danvers Drilling Delivers a Globally Significant Copper Intersection
